Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0001193125-24-194475
Filing Date
2024-08-06
Accepted
2024-08-06 09:03:29
Documents
10
Effectiveness Date
2024-08-06

Document Format Files

Seq Description Document Type Size
1 S-3ASR d845594ds3asr.htm S-3ASR 168527
2 EX-5.1 d845594dex51.htm EX-5.1 5388
3 EX-23.1 d845594dex231.htm EX-23.1 1908
4 EX-FILING FEES d845594dexfilingfees.htm EX-FILING FEES 16778
5 GRAPHIC g845594dsp029a.jpg GRAPHIC 4192
6 GRAPHIC g845594dsp029b.jpg GRAPHIC 5278
7 GRAPHIC g845594dsp029c.jpg GRAPHIC 6168
8 GRAPHIC g845594g10r40.jpg GRAPHIC 84023
9 GRAPHIC g845594g79r23.jpg GRAPHIC 62509
10 GRAPHIC g845594g84l03.jpg GRAPHIC 52533
  Complete submission text file 0001193125-24-194475.txt   484427
Mailing Address 2882 SAND HILL ROAD SUITE 106 MENLO PARK CA 94025
Business Address 2882 SAND HILL ROAD SUITE 106 MENLO PARK CA 94025 650-460-8308
Summit Therapeutics Inc. (Filer) CIK: 0001599298 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3ASR | Act: 33 | File No.: 333-281273 | Film No.: 241177285
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)